The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis
P. D. Molyneux(UCL Australia), D. H. Miller(Pacific Environment), Mahdiyeh Khabbaz Koche Ghazi(UCL Australia), Nicholas Losseff(UCL Australia), Frank Dahlke(Ophthalmology Clinic), David W. Hahn(University of Arizona), Ludwig Kappos(University Hospital of Basel), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Alan J. Thompson(Queen Mary University of London), Gareth J. Barker(King's College London), Carlo Pozzilli(Sapienza University of Rome), Tarek Yousry(National Hospital for Neurology and Neurosurgery), Chris H. Polman(Vrije Universiteit Amsterdam), K. Beckmann(Ophthalmology Clinic), Klaus Wagner(UCL Australia), Massimo Filippi(Vita-Salute San Raffaele University)
Cited by 241
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k